| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
q Coupling Specificity
Department of Biochemistry and Molecular Biology (M.Y., W.W., M.Z., B.M.S.), University of Texas Medical School Houston, Houston, Texas 77030; and Department of Human Genetics (A.P., O.L.), Baylor College of Medicine, Houston, Texas 77030
Address all correspondence and requests for reprints to: Dr. Barbara Sanborn, Department of Biochemistry and Molecular Biology, University of Texas Medical School, P.O. Box 20708, Houston, Texas 77225. E-mail: .
To identify structural elements important to specific G
q coupling in the oxytocin receptor (OTR), intracellular domains were exchanged between OTR and G
s-coupled vasopressin V2 receptors (V2Rs). Substitution of sequence from the second (2i) and third (3i) intracellular domains of V2R into comparable positions in OTR markedly reduced ligand affinity and resulted in a loss of G
q coupling. Substitution of the 2i domain of OTR into V2R decreased ligand affinity and vasopressin-stimulated adenylyl cyclase activity and only slightly increased phosphatidylinositide turnover. In contrast, substitution of the OTR3i domain into V2R produced a receptor chimera with high ligand affinity, decreased vasopressin-stimulated adenylyl cyclase activity, and markedly enhanced ligand-stimulated phosphatidylinositide turnover. The C-terminal 36 amino acids, but not the N-terminal 13 amino acids, of the OTR3i domain contained the determinants critical for enhanced activation of PLC. Mutation of a single lysine in the C-terminal OTR3i sequence to the corresponding V2R residue (valine) eliminated the enhanced ability of the V2R chimera to stimulate PLC but did not affect maximal adenylyl cyclase stimulation. Furthermore, mutation of this residue (K270) in wild-type OTR completely abolished the ability of the receptor to stimulate phosphatidylinositide turnover, with only a small reduction in ligand affinity. These data demonstrate that OTR K270 is critically important in the stimulation by OTR of phosphatidylinositide turnover and that this determinant can also increase this activity in the V2R chimera. Mutation of K270 also adversely affects the ability of OTR to stimulate ERK1/2 phosphorylation. Therefore, this residue plays an important role in the specificity of OTR/G
q/PLC coupling.
This article has been cited by other articles:
![]() |
M. Zhong, D. A. Murtazina, J. Phillips, C.-Y. Ku, and B. M. Sanborn Multiple Signals Regulate Phospholipase CBeta3 in Human Myometrial Cells Biol Reprod, June 1, 2008; 78(6): 1007 - 1017. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhong, B. Parish, D. A. Murtazina, C.-Y. Ku, and B. M. Sanborn Amino acids in the COOH-terminal region of the oxytocin receptor third intracellular domain are important for receptor function Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E977 - E984. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Saito, M. Tetsuka, S. Saito, K. Imai, A. Yoshikawa, H. Doi, and K. Maruyama Arginine Residue 155 in the Second Intracellular Loop Plays a Critical Role in Rat Melanin-Concentrating Hormone Receptor 1 Activation Endocrinology, August 1, 2005; 146(8): 3452 - 3462. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Deshpande, T. A. White, S. Dogan, T. F. Walseth, R. A. Panettieri, and M. S. Kannan CD38/cyclic ADP-ribose signaling: role in the regulation of calcium homeostasis in airway smooth muscle Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L773 - L788. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Neumann, G. Krause, M. Claus, and R. Paschke Structural Determinants for G Protein Activation and Selectivity in the Second Intracellular Loop of the Thyrotropin Receptor Endocrinology, January 1, 2005; 146(1): 477 - 485. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhong, M. Yang, and B. M. Sanborn Extracellular Signal-Regulated Kinase 1/2 Activation by Myometrial Oxytocin Receptor Involves G{alpha}qG{beta}{gamma} and Epidermal Growth Factor Receptor Tyrosine Kinase Activation Endocrinology, July 1, 2003; 144(7): 2947 - 2956. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |